Cardiovascular Disease Doctors in Lumberton, NC Accepting Medicare

6 Cardiovascular Disease doctors found. Showing 1 - 6

Dr. Christopher Ronald Walters, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 403 W 27th St, Lumberton, NC 28358 Phone: 910-671-6619

Sadanand Belinje Hegde, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 725 Oakridge Blvd Ste A3, Lumberton, NC 28358 Phone: 910-738-1141    Fax: 910-738-6011

Robert George Everhart, M.D. Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 2936 N Elm St, Suite 102, Lumberton, NC 28358 Phone: 919-684-8111

Dr. Sagir Ahmed, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2936 N Elm St Ste 102, Lumberton, NC 28358 Phone: 910-671-6619    Fax: 910-608-0487

Andrew J Doorey, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2610 N Elm St, Lumberton, NC 28358 Phone: 910-671-6177    Fax: 910-671-6770

Dr. Xiuxian Alan Zhu, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2936 N Elm St Ste 102, Lumberton, NC 28358 Phone: 910-671-6619    Fax: 910-608-0487

News Archive

Excelitas Technologies® Corp. and Quorum Technologies Present Microscopy Systems for Optogenetics Webinar

Excelitas Technologies® Corp. and Quorum Technologies will present a webinar entitled "How Can I Build a Microscopy System for Optogenetics?" led by featured speakers Kavita Aswani, Ph.D., senior applications scientist for the Life Sciences products at Excelitas Technologies, and Ryan Geil, M.Sc., service manager at Quorum Technologies Inc. The session will be moderated by Photonics Media and takes place on Thursday, November 12 at 1:00 pm (EST).

Nplate reduces treatment failure and splenectomies in adults with chronic immune thrombocytopenia

Amgen Inc. today announced the publication of results from the first open-label study to compare Nplate® (romiplostim) treatment to standard of care therapies (SOC) in non-splenectomized adult patients with chronic immune thrombocytopenia (ITP). The study results, which were published today in the New England Journal of Medicine (NEJM), show that both the incidence of treatment failure and need for splenectomy were reduced among the Nplate-treated patients.

Home-birth-like experience in hospitals ultimately safer, more satisfying and cost effective for patients

Advocates of planned home birth have emphasized its benefits for patient safety, patient satisfaction, cost effectiveness, and respect for women's rights. A clinical opinion paper published in the American Journal of Obstetrics and Gynecology critically evaluates each of these claims in its effort to identify professionally appropriate responses of obstetricians and other concerned physicians to planned home birth.

K2M opens direct sales and distribution office in the United Kingdom

K2M, Inc., the spinal device company developing innovative solutions for the treatment of complex spinal pathologies, today announced the opening of a direct sales and distribution office in the United Kingdom. K2M's expansion into the UK began in 2008 with the CE Mark clearance and successful introduction of its RANGE® Spinal System, MESA® Spinal System, DENALI® Spinal System, PYRENEES® Cervical Plate System, and ALEUTIAN® Interbody Systems.

Baxter enters definitive agreement to acquire Baxa

Baxter International Inc. announced today that it has entered into a definitive agreement to acquire Baxa Corporation, a privately held company based in Englewood, Colo., with additional operations in Florida and the United Kingdom.

Read more Medical News

› Verified 3 days ago